ArticleCancer science2016

Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.

Panpan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.